Literature DB >> 21958373

Preferential replication of vaccinia virus in the ovaries is independent of immune regulation through IL-10 and TGF-β.

Yuan Zhao1, Yan Fei Adams, Michael Croft.   

Abstract

Vaccinia virus (VACV) exhibits a strong tropism for ovarian tissue and can cause ovary pathology and sterility. Why VACV preferentially accumulates in this organ is not known. Here we show that multiple immune cell populations infiltrated the ovaries following VACV infection, including virus-specific CD8 T cells making both IFN-γ and TNF. This was also accompanied by the induction of interleukin (IL)-10 and TGF-β, suggesting that VACV may exploit the ovarian environment for immune evasion via induction of these suppressive cytokines. To test this we used several strategies, including neutralizing these cytokines, and exogenous targeting of the T-cell response, to determine if this inhibited virus replication in the ovaries. We found that the VACV-specific CD8 T-cell immunity and the clearance of virus were not enhanced in the ovaries of infected mice in which IL-10 receptor (IL-10R) was blocked with antagonist antibody. VACV replication was also only moderately affected in the ovaries of infected IL-10 knockout mice. Similarly, blockade of TGF-β with antagonist antibody demonstrated no effect on CD8 T-cell immunity or VACV replication. Lastly, an agonist antibody targeting the tumor necrosis factor receptor superfamily member OX40 (TNFRSF4) enhanced the number of VACV-specific CD8 T cells producing IFN-γ in lymphoid tissue, but had no effect on CD8 T-cell infiltration of the ovaries or on the viral load. Collectively, the results indicate that preferential replication of VACV in the ovaries may not be dependent on immune suppressive mechanisms in this tissue.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21958373      PMCID: PMC3189386          DOI: 10.1089/vim.2011.0020

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  50 in total

1.  Live attenuated vaccinia and other poxviruses as delivery systems: public health issues.

Authors:  M E Perkus; J Taylor; J Tartaglia; S Pincus; E B Kauffman; J A Tine; E Paoletti
Journal:  Ann N Y Acad Sci       Date:  1995-05-31       Impact factor: 5.691

Review 2.  Involvement of leukocytes and cytokines in the ovulatory process and corpus luteum function.

Authors:  M Brännström; R J Norman
Journal:  Hum Reprod       Date:  1993-10       Impact factor: 6.918

3.  Transforming growth factor-beta expression and natural killer cell responses during virus infection of normal, nude, and SCID mice.

Authors:  H C Su; R Ishikawa; C A Biron
Journal:  J Immunol       Date:  1993-11-01       Impact factor: 5.422

4.  Effects of virally expressed interleukin-10 on vaccinia virus infection in mice.

Authors:  M G Kurilla; S Swaminathan; R M Welsh; E Kieff; R R Brutkiewicz
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

5.  Immune response in mice that lack the interferon-gamma receptor.

Authors:  S Huang; W Hendriks; A Althage; S Hemmi; H Bluethmann; R Kamijo; J Vilcek; R M Zinkernagel; M Aguet
Journal:  Science       Date:  1993-03-19       Impact factor: 47.728

6.  IFN-gamma receptor-deficient mice generate antiviral Th1-characteristic cytokine profiles but altered antibody responses.

Authors:  V E Schijns; B L Haagmans; E O Rijke; S Huang; M Aguet; M C Horzinek
Journal:  J Immunol       Date:  1994-09-01       Impact factor: 5.422

7.  Human cytomegalovirus infection induces transcription and secretion of transforming growth factor beta 1.

Authors:  S Michelson; J Alcami; S J Kim; D Danielpour; F Bachelerie; L Picard; C Bessia; C Paya; J L Virelizier
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

8.  Leukocyte subpopulations in the rat corpus luteum during pregnancy and pseudopregnancy.

Authors:  M Brännström; L Giesecke; I C Moore; C J van den Heuvel; S A Robertson
Journal:  Biol Reprod       Date:  1994-05       Impact factor: 4.285

9.  Response to influenza infection in mice with a targeted disruption in the interferon gamma gene.

Authors:  M B Graham; D K Dalton; D Giltinan; V L Braciale; T A Stewart; T J Braciale
Journal:  J Exp Med       Date:  1993-11-01       Impact factor: 14.307

10.  In vivo depletion of interferon-gamma leads to susceptibility of A/J mice to mouse hepatitis virus 3 infection.

Authors:  M A Lucchiari; M Modolell; K Eichmann; C A Pereira
Journal:  Immunobiology       Date:  1992-09       Impact factor: 3.144

View more
  12 in total

1.  MyD88-dependent immunity to a natural model of vaccinia virus infection does not involve Toll-like receptor 2.

Authors:  Michael L Davies; Janet J Sei; Nicholas A Siciliano; Ren-Huan Xu; Felicia Roscoe; Luis J Sigal; Laurence C Eisenlohr; Christopher C Norbury
Journal:  J Virol       Date:  2014-01-08       Impact factor: 5.103

2.  Clinical and virological features of first human monkeypox cases in Germany.

Authors:  Sebastian Noe; Sabine Zange; Clemens-Martin Wendtner; Roman Wölfel; Michael Seilmaier; Markus H Antwerpen; Thomas Fenzl; Jochen Schneider; Christoph D Spinner; Joachim J Bugert
Journal:  Infection       Date:  2022-07-11       Impact factor: 7.455

3.  CD69 Deficiency Enhances the Host Response to Vaccinia Virus Infection through Altered NK Cell Homeostasis.

Authors:  Laura Notario; Elisenda Alari-Pahissa; Antonio de Molina; Pilar Lauzurica
Journal:  J Virol       Date:  2016-06-24       Impact factor: 5.103

4.  IL-1R Type 1-Deficient Mice Demonstrate an Impaired Host Immune Response against Cutaneous Vaccinia Virus Infection.

Authors:  Tian Tian; Michelle Qiushuang Jin; Krista Dubin; Sandra L King; Wolfram Hoetzenecker; George F Murphy; Chen Amy Chen; Thomas S Kupper; Robert C Fuhlbrigge
Journal:  J Immunol       Date:  2017-05-03       Impact factor: 5.426

5.  Development of a Safe and Effective Vaccinia Virus Oncolytic Vector WR-Δ4 with a Set of Gene Deletions on Several Viral Pathways.

Authors:  Ernesto Mejías-Pérez; Liliana Carreño-Fuentes; Mariano Esteban
Journal:  Mol Ther Oncolytics       Date:  2017-12-05       Impact factor: 7.200

6.  A systemic macrophage response is required to contain a peripheral poxvirus infection.

Authors:  Michael L Davies; Nikhil J Parekh; Lauren W Kaminsky; Chetna Soni; Irene E Reider; Tracy E Krouse; Matthew A Fischer; Nico van Rooijen; Ziaur S M Rahman; Christopher C Norbury
Journal:  PLoS Pathog       Date:  2017-06-14       Impact factor: 6.823

7.  IL-12 is required for mTOR regulation of memory CTLs during viral infection.

Authors:  K Garcia; Z Sun; E Mattson; L Li; K Smyth; Z Xiao
Journal:  Genes Immun       Date:  2014-06-05       Impact factor: 2.676

8.  L-selectin Is Essential for Delivery of Activated CD8(+) T Cells to Virus-Infected Organs for Protective Immunity.

Authors:  Rebar N Mohammed; H Angharad Watson; Miriam Vigar; Julia Ohme; Amanda Thomson; Ian R Humphreys; Ann Ager
Journal:  Cell Rep       Date:  2016-01-21       Impact factor: 9.423

9.  Locally Produced IL-10 Limits Cutaneous Vaccinia Virus Spread.

Authors:  Stephanie S Cush; Glennys V Reynoso; Olena Kamenyeva; Jack R Bennink; Jonathan W Yewdell; Heather D Hickman
Journal:  PLoS Pathog       Date:  2016-03-18       Impact factor: 6.823

10.  Deletion of F4L (ribonucleotide reductase) in vaccinia virus produces a selective oncolytic virus and promotes anti-tumor immunity with superior safety in bladder cancer models.

Authors:  Kyle G Potts; Chad R Irwin; Nicole A Favis; Desmond B Pink; Krista M Vincent; John D Lewis; Ronald B Moore; Mary M Hitt; David H Evans
Journal:  EMBO Mol Med       Date:  2017-05       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.